Despite a Supreme Court ruling against race-conscious admissions, medical school applicants can still recognize their diverse backgrounds in personal essays, leaving a small opening for affirmative action, according to an expert.In 2023, the U.S. Supre…
Author: Healio ophthalmology
Jennifer Loh, MD, shares preferred technique for IOL exchange
KIAWAH ISLAND, S.C. — In this exclusive Healio Video Perspective from Kiawah Eye, Jennifer M. Loh, MD, discusses her technique for IOL exchange.While there are several ways to remove an IOL, Loh’s preferred method has four steps: separating the anterio…
ILYX-002 rapidly improves immune-mediated dry eye disease in phase 2 trial
Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press release from Iolyx Therapeutics.“What’s amazing about ILYX…
Should ophthalmologists consider vitrectomy for vitreous floaters?
SEVILLE, Spain — Do surgeons feel comfortable offering vitrectomy as a treatment for floaters? What is their attitude toward patients who are affected to the point of seeking surgery despite the risks involved?Two surgeons with different views debated …
Integrating oculoplastics into general ophthalmology practice
Oculoplastics can provide comprehensive ophthalmologists with an opportunity to improve patient care, expand their services and increase practice revenue.An aging population and increasing demand for both functional and cosmetic oculoplastic procedures…
Bausch + Lomb launches Blink Nourish, Blink Boost lubricating eye drops in US
Bausch + Lomb launched two preservative-free lubricating eye drops, Blink Nourish and Blink Boost, in the U.S., according to a press release.“Blink Boost and Blink Nourish eye drops are designed to help relieve dry, irritated eyes by rebalancing and re…
Astigmatism rates, severity higher in children after COVID-19 pandemic
The prevalence and severity of refractive and corneal astigmatism in children rose after the COVID-19 pandemic, according to a study published in JAMA Ophthalmology.Ka Wai Kam, MSc, and colleagues wrote that lifestyle changes during the pandemic led to…
Study: Proposed Medicaid cuts could lead to thousands of preventable deaths annually
Congress passing the controversial One Big Beautiful Bill Act could leave millions without insurance and lead to at least 16,000 annual preventable deaths, according to research published in Annals of Internal Medicine.In May, the House of Representati…
Sex- and gender-informed approaches a prerequisite for precision medicine
In 2023, an annual awareness campaign on dry eye disease was launched in Italy in collaboration with 400 ophthalmology clinics and hospital departments and with the support of AbbVie.We named the campaign “Vediamoci rOSa” (“See pink”), in which the two…
Beveled arcuate incisions yield ‘strong’ astigmatism correction at 12 months
LOS ANGELES — Femtosecond laser-created beveled arcuate incisions yielded “robust and persistent” astigmatism correction, Joaquin O. De Rojas, MD, ABO, told Healio at the American Society of Cataract and Refractive Surgery meeting.According to De Rojas…
Eye differences between women, men need to be considered for diagnosis and treatment
There are subtle but significant differences in the morphology and biochemistry of the eye between men and women.These differences may affect disease susceptibility, symptoms and progression, response to therapy, outcomes of surgical interventions and …
Gene therapy shows long-term visual acuity improvements in retinitis pigmentosa
SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa.Sadda said patients with retinitis pigmentosa experienced su…
For patients with aniridia, consider artificial iris implant
KIAWAH ISLAND, S.C. — Consider using an artificial iris implant in patients with congenital or acquired aniridia, Karolinne M. Rocha, MD, PhD, told Healio at Kiawah Eye.An implant allows ophthalmologists to perform certain suture techniques in cases in…
AMA strengthens guidance on corporate relationships in medicine
At the AMA’s annual meeting, members voted to strengthen the organization’s guidance for any physicians considering entering a relationship with a corporation.Investment from corporations “can offer an alternative to selling a practice to a hospital or…
Consider alternatives to surgery for rejuvenating eyelid skin
KIAWAH ISLAND, S.C. — Ophthalmologists and patients should consider alternatives to surgical intervention for eyelid skin rejuvenation, Gene R. Howard, MPH, MD, said in this Healio Video Perspective from Kiawah Eye.Red light therapy, exosomes, micronee…
Harrow acquires US commercial rights to Byqlovi
Editor’s note: This is a developing news story. Please check back soon for updates.Harrow acquired the U.S. commercial rights for Byqlovi through a licensing agreement with Formosa Pharmaceuticals, according to a press release.The FDA approved Byqlovi …
VG801 gene therapy in Stargardt disease receives rare pediatric disease designation
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA granted VG801 rare pediatric disease designation in Stargardt disease, according to a press release from VeonGen Therapeutics.VeonGen Therapeutics, formerly know…
Cross-linking under general anesthesia safe in difficult-to-treat patients
LOS ANGELES — Performing corneal collagen cross-linking under general anesthesia is an option in pediatric patients and patients with developmental delays.In this Healio Video Perspective from the ASCRS meeting, Maanasa Indaram, MD, said these patients…
FDA accepts new drug application for Brimochol PF for presbyopia treatment
The FDA accepted a new drug application for Brimochol PF for the treatment of presbyopia and set a Prescription Drug User Fee Act date of Jan. 28, 2026, according to a press release from Tenpoint Therapeutics.Brimochol PF combines carbachol and brimoni…
Lifitegrast shows improvement in dry eye as early as 2 weeks
LOS ANGELES — Lifitegrast demonstrated positive results for the treatment of dry eye disease at a rapid rate, according to a study presented at the American Society of Cataract and Refractive Surgery meeting.The study investigated the impact of Xiidra …